Business Context and Reporting Period
This Form 8-K Current Report was filed by SeaStar Medical Holding Corporation on August 13, 2025. The filing addresses significant changes in the Company's executive leadership, specifically the departure of the Chief Financial Officer and the appointment of interim replacements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and associated compensation obligations rather than operational financial performance.
Material Changes
- Departure of CFO: David Green, Chief Financial Officer and Treasurer, was terminated effective August 14, 2025. The termination was without "Cause."
- Interim Appointments: On August 19, 2025, the Board appointed Eric Schlorff (CEO) as interim Chief Financial Officer and Treasurer. Bradford Towne (Controller) was appointed as the principal accounting officer.
- Compensation Obligations: Subject to a separation agreement, the Company expects to pay Mr. Green approximately $300,000 in continued base salary over 12 months, provide COBRA coverage for up to 18 months, and accelerate the vesting of unvested restricted stock units.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, outlook, or general risk factors. The primary contingency noted is the requirement for Mr. Green to enter into a mutually agreeable separation and release agreement to trigger the specified termination payments and accelerated vesting.
Investor Verification Checklist
- Confirm the execution of the separation and release agreement with David Green to validate the $300,000 payout and accelerated vesting.
- Monitor the timeline for the search and appointment of a permanent Chief Financial Officer.
- Review the Company's next periodic report (10-Q or 10-K) for the impact of the CFO transition on financial reporting and internal controls.